Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D. Gareth Evans"'
Autor:
Kelly L, Bolton, Georgia, Chenevix-Trench, Cindy, Goh, Siegal, Sadetzki, Susan J, Ramus, Beth Y, Karlan, Diether, Lambrechts, Evelyn, Despierre, Daniel, Barrowdale, Lesley, McGuffog, Sue, Healey, Douglas F, Easton, Olga, Sinilnikova, Javier, Benítez, María J, García, Susan, Neuhausen, Mitchell H, Gail, Patricia, Hartge, Susan, Peock, Debra, Frost, D Gareth, Evans, Rosalind, Eeles, Andrew K, Godwin, Mary B, Daly, Ava, Kwong, Edmond S K, Ma, Conxi, Lázaro, Ignacio, Blanco, Marco, Montagna, Emma, D'Andrea, Maria Ornella, Nicoletto, Sharon E, Johnatty, Susanne Krüger, Kjær, Allan, Jensen, Estrid, Høgdall, Ellen L, Goode, Brooke L, Fridley, Jennifer T, Loud, Mark H, Greene, Phuong L, Mai, Angela, Chetrit, Flora, Lubin, Galit, Hirsh-Yechezkel, Gord, Glendon, Irene L, Andrulis, Amanda E, Toland, Leigha, Senter, Martin E, Gore, Charlie, Gourley, Caroline O, Michie, Honglin, Song, Jonathan, Tyrer, Alice S, Whittemore, Valerie, McGuire, Weiva, Sieh, Ulf, Kristoffersson, Håkan, Olsson, Åke, Borg, Douglas A, Levine, Linda, Steele, Mary S, Beattie, Salina, Chan, Robert L, Nussbaum, Kirsten B, Moysich, Jenny, Gross, Ilana, Cass, Christine, Walsh, Andrew J, Li, Ronald, Leuchter, Ora, Gordon, Montserrat, Garcia-Closas, Simon A, Gayther, Stephen J, Chanock, Antonis C, Antoniou, Paul D P, Pharoah, Roger, Milne
Publikováno v:
JAMA. 307(4)
Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 rema
Autor:
Fergus J. Couch, D. Gareth Evans, Patricia A. Ganz, Olufunmilayo I. Olopade, Henry T. Lynch, Christian F. Singer, Wendy S. Rubinstein, Claudine Isaacs, Susan L. Neuhausen, Judy Garber, Tara M. Friebel, Rosalind A. Eeles, Gail E. Tomlinson, Joellen M. Schildkraut, Joanne L. Blum, Ellen T. Matloff, Mary B. Daly, Laura Van T'veer, Gabriella Pichert, Jeffrey N. Weitzel, Timothy R. Rebbeck, Susan M. Domchek, Nadine Tung
Publikováno v:
JAMA. 304:967
Context Mastectomy and salpingo-oophorectomy are widely used by carriers of BRCA1 or BRCA2 mutations to reduce their risks of breast and ovarian cancer. Objective To estimate risk and mortality reduction stratified by mutation and prior cancer status
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.